首页> 外文会议>第四届国际分子模拟与信息技术应用学术会议(The 4th International Conference of Molecular Simulations and Applied Informatics Technologies)论文集 >Computational modeling and functional analysis of Herpes simplex virus type-1 thymidine kinase and Escherichia coli cytosine deaminase fusion protein
【24h】

Computational modeling and functional analysis of Herpes simplex virus type-1 thymidine kinase and Escherichia coli cytosine deaminase fusion protein

机译:单纯疱疹病毒1型胸苷激酶和大肠杆菌胞嘧啶脱氨酶融合蛋白的计算建模和功能分析

获取原文

摘要

Herpes simplex virus type-1 thymidine kinase (HSV-1TK) and Escherichia coli cytosine deaminase (CD) fusion protein was designed using Insightll software. The structural rationality of the fusion proteins incorporating a series of flexible linker peptide was analyzed, and a suitable linker peptide was chosen for further investigated. The recombinant plasmid containing the coding regions of HSV-1TK and CD cDNA connected by this linker peptide coding sequence was generated and subsequently transfected into the human embryonic kidney 293 cells (HEK.293). The Western blotting indicated that the recombinant fusion protein existed as a dimer with a molecular weight of approximately 90 kDa. The toxicity of the prodrug on the recombinant plasmid-transfected human lung cancer cell line NCIH460 was evaluated, which showed that TKglyCD-expressing cells conferred upon cells prodrug sensitivities equivalent to that observed for each enzyme independently. Most noteworthy, cytotoxicity could be enhanced by concurrently treating TKglyCD-express ing cells with prodrugs GCV and 5-FC. The results indicate that we have successfully constructed a HSV-lTKglyCD fusion gene which might have a potential application for cancer gene therapy.
机译:使用Insightll软件设计了单纯疱疹病毒1型胸苷激酶(HSV-1TK)和大肠杆菌胞嘧啶脱氨酶(CD)融合蛋白。分析了融合有一系列柔性接头肽的融合蛋白的结构合理性,并选择了合适的接头肽进行进一步研究。产生了包含通过该接头肽编码序列连接的HSV-1TK和CD cDNA的编码区的重组质粒,随后将其转染到人胚胎肾293细胞(HEK.293)中。 Western印迹表明重组融合蛋白以二聚体形式存在,分子量约为90kDa。评估了前药对重组质粒转染的人肺癌细胞NCIH460的毒性,结果表明,表达TKglyCD的细胞赋予细胞前药敏感性,其敏感性独立于每种酶。最值得注意的是,通过同时用前药GCV和5-FC处理表达TKglyCD的细胞可以增强细胞毒性。结果表明,我们已经成功构建了HSV-1TKglyCD融合基因,该基因可能在癌症基因治疗中具有潜在的应用前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号